Aldevron Breakthrough Blog

Optimizing mRNA Template Design

September 24, 2025 by Derek Jacobs

A Smarter Starting Point for RNA Workflows

In RNA research, the design of your mRNA template can make or break the success of your experiment. Whether you're developing a vaccine candidate, testing a therapeutic payload, or simply trying to boost protein expression in a model system, the untranslated regions (UTRs) of your construct deserve more attention than they often get.

The 5’ UTR plays a critical role in translation efficiency and RNA stability. But designing one from scratch that performs well across cell types can be a time-consuming and uncertain process. That’s why many researchers are turning to pre-validated backbone tools that incorporate optimized UTR sequences.

Why use a pre-validated UTR backbone?
Instead of starting from a blank slate, these tools offer a shortcut: UTR sequences that have already been tested for performance in multiple cell lines, selected from dozens of candidates based on expression data. Some are derived from viral or human sources known to support strong translation, and they’re packaged in vectors that are ready for cloning or synthesis.

For bench scientists, this means fewer design iterations, faster time to results, and more confidence in the quality of the RNA produced. Whether you're working with in vitro transcription (IVT) or planning to scale up for preclinical studies, having a reliable backbone can streamline your workflow.

Flexible integration into your workflow
These backbone tools are designed to be flexible. You can use them as part of a DIY template assembly process by cloning your coding sequence (CDS) into an off-the-shelf plasmid, or you can integrate them into a gene synthesis workflow where the entire cassette (promoter, UTR, CDS, poly(A)) is assembled and verified before delivery.

Some systems even allow for easy modification of the 3’ poly(A) tail, giving you control over transcript stability and length. And because the UTRs are already optimized, you can focus on your payload rather than troubleshooting expression issues.

Built for research, ready for discovery
These tools are typically offered for research use without licensing fees, making them accessible for academic labs and early-stage biotech teams. While they’re not intended for diagnostic or clinical use without additional permissions, they’re ideal for exploratory work, proof-of-concept studies, and early development pipelines. For simplifying your mRNA design process and improving the quality of your RNA constructs, these backbone tools are worth exploring.

Subscribe to our blog

ABOUT THE AUTHOR

Derek Jacobs

Derek Jacobs, PhD, is Marketing Manager in Cell & Gene Therapy at Aldevron a marketing leader specializing in advanced therapeutic modalities, with a focus on RNA-based technologies and personalized medicine. He brings a strategic lens to upstream marketing, product launches, and digital transformation initiatives.

With a PhD in Molecular Genetics, Derek began his career in quality control at bioMérieux before transitioning into the cell therapy CDMO space at Catalent.